Concord Biotech Announces Successful Completion of EU GMP Inspection

About this update from Concord Biotech Ltd.

Concord Biotech Limited announced the successful completion of the European Union Good Manufacturing Practice (EU GMP) inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility in Dholka, Gujarat. The inspection was conducted from July 14, 2025, to July 18, 2025.The company stated that this achievement underscores its commitment to maintaining high standards of quality, safety, and regulatory compliance. The announcement was made on July 18, 2025, in a filing with the National Stock Exchange of India Ltd. and BSE Limited.Hina Ronak Patel, the Company Secretary and Compliance Officer of Concord Biotech Limited, digitally signed the announcement.The company's registered office and plant are located at 1482-1486, Trased Road, Dholka, Dist. Ahmedabad-382225, India.

View stock analysis, news, and events for Concord Biotech Ltd.